Activation of non-ischemic, hypoxia-inducible signalling pathways up-regulate cytoprotective genes in the murine liver

Journal of Hepatology

Volumn 47, Issue 4, 2007, Pages 538-545

  Plock, Jan ^a   Frese, Steffen ^a   Keogh, Adrian ^a   Bisch Knaden, Sonja ^a   Ayuni, Erick ^a   Corazza, Nadia ^a   Weikert, Christian ^a   Jakob, Stephan ^a   Erni, Dominique ^a   Dufour, Jean François ^a   Brunner, Thomas ^a   Candinas, Daniel ^a   Stroka, Deborah ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Hepatoprotective genes; Hypoxia; Hypoxia inducible factor 1; Liver; Mouse

Indexed keywords

CASPASE 3; FAS ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1; LAMIN A;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVITY; LIVER ISCHEMIA; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; OXYGEN SATURATION; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE INJURY; UPREGULATION;

ANIMALS; ANOXIA; CYTOPROTECTION; GENE EXPRESSION REGULATION; HYPOXIA-INDUCIBLE FACTOR 1; ISCHEMIC PRECONDITIONING; LIVER; MICE; MICE, INBRED STRAINS; OXYGEN CONSUMPTION; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 34548252551     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.04.016     Document Type: Article

References (44)

1. Jungermann K., and Kietzmann T. Oxygen: modulator of metabolic zonation and disease of the liver. Hepatology 31 (2000) 255-260
2. Rosmorduc O., Wendum D., Corpechot C., Galy B., Sebbagh N., Raleigh J., et al. Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis. Am J Pathol 155 (1999) 1065-1073
3. Cummins E.P., and Taylor C.T. Hypoxia-responsive transcription factors. Pflugers Arch 450 (2005) 363-371
4. Wang G.L., and Semenza G.L. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem 268 (1993) 21513-21518
5. Salceda S., and Caro J. Hypoxia-inducible factor 1alpha (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 272 (1997) 22642-22647
6. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95 (1998) 7987-7992
7. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399 (1999) 271-275
8. Ohh M., and Kaelin Jr. W.G. The von Hippel-Lindau tumour suppressor protein: new perspectives. Mol Med Today 5 (1999) 257-263
9. 2 sensing. Science 292 (2001) 464-468
10. 2-regulated prolyl hydroxylation. Science 292 (2001) 468-472
11. Yu F., White S.B., Zhao Q., and Lee F.S. HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc Natl Acad Sci USA 98 (2001) 9630-9635
12. Poellinger L., and Johnson R.S. HIF-1 and hypoxic response: the plot thickens. Curr Opin Genet Dev 14 (2004) 81-85
13. Lee P.J., Jiang B.H., Chin B.Y., Iyer N.V., Alam J., Semenza G.L., et al. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 272 (1997) 5375-5381
14. Ke B., Buelow R., Shen X.D., Melinek J., Amersi F., Gao F., et al. Heme oxygenase 1 gene transfer prevents CD95/Fas ligand-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway. Hum Gene Ther 13 (2002) 1189-1199
15. Tazuke S.I., Mazure N.M., Sugawara J., Carland G., Faessen G.H., Suen L.F., et al. Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. Proc Natl Acad Sci USA 95 (1998) 10188-10193
16. Leu J.I., Crissey M.A., and Taub R. Massive hepatic apoptosis associated with TGF-β1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice. J Clin Invest 111 (2003) 129-139
17. Kovalovich K., Li W., DeAngelis R., Greenbaum L.E., Ciliberto G., and Taub R. Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. J Biol Chem 276 (2001) 26605-26613
18. 4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression. J Hepatol 42 (2005) 548-556
19. Wuestefeld T., Klein C., Streetz K.L., Betz U., Lauber J., Buer J., et al. Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J Biol Chem 278 (2003) 11281-11288
20. Contaldo C., Plock J., Djonov V., Leunig M., Banic A., and Erni D. The influence of trauma and ischemia on carbohydrate metabolites monitored in hamster flap tissue. Anesth Analg 100 (2005) 817-822
21. Stroka D.M., Burkhardt T., Desbaillets I., Wenger R.H., Neil D.A., Bauer C., et al. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 15 (2001) 2445-2453
22. Arteel G.E., Thurman R.G., Yates J.M., and Raleigh J.A. Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br J Cancer 72 (1995) 889-895
23. Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzawa A., Kasugai T., Kitamura Y., et al. Lethal effect of the anti-Fas antibody in mice. Nature 364 (1993) 806-809
24. Selzner N., Rudiger H., Graf R., and Clavien P.A. Protective strategies against ischemic injury of the liver. Gastroenterology 125 (2003) 917-936
25. Martinive P., Defresne F., Bouzin C., Saliez J., Lair F., Gregoire V., et al. Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies. Cancer Res 66 (2006) 11736-11744
26. Leu J.I., Crissey M.A., Craig L.E., and Taub R. Impaired hepatocyte DNA synthetic response posthepatectomy in insulin-like growth factor binding protein 1-deficient mice with defects in C/EBP beta and mitogen-activated protein kinase/extracellular signal-regulated kinase regulation. Mol Cell Biol 23 (2003) 1251-1259
27. Amersi F., Buelow R., Kato H., Ke B., Coito A.J., Shen X.D., et al. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 104 (1999) 1631-1639
28. Lai I.R., Ma M.C., Chen C.F., and Chang K.J. The protective role of heme oxygenase-1 on the liver after hypoxic preconditioning in rats. Transplantation 77 (2004) 1004-1008
29. Redaelli C.A., Tian Y.H., Schaffner T., Ledermann M., Baer H.U., and Dufour J.F. Extended preservation of rat liver graft by induction of heme oxygenase-1. Hepatology 35 (2002) 1082-1092
30. Parsa C.J., Matsumoto A., Kim J., Riel R.U., Pascal L.S., Walton G.B., et al. A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest 112 (2003) 999-1007
31. Brines M.L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N.C., Cerami C., et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 97 (2000) 10526-10531
32. Grimm C., Wenzel A., Groszer M., Mayser H., Seeliger M., Samardzija M., et al. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 8 (2002) 718-724
33. Cai Z., Manalo D.J., Wei G., Rodriguez E.R., Fox-Talbot K., Lu H., et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108 (2003) 79-85
34. Kovalovich K., DeAngelis R.A., Li W., Furth E.E., Ciliberto G., and Taub R. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 31 (2000) 149-159
35. Streetz K.L., Tacke F., Leifeld L., Wustefeld T., Graw A., Klein C., et al. Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases. Hepatology 38 (2003) 218-229
36. Streetz K.L., Wustefeld T., Klein C., Kallen K.J., Tronche F., Betz U.A., et al. Lack of gp130 expression in hepatocytes promotes liver injury. Gastroenterology 125 (2003) 532-543
37. Cooper J.T., Stroka D.M., Brostjan C., Palmetshofer A., Bach F.H., and Ferran C. A20 blocks endothelial cell activation through a NF-κB-dependent mechanism. J Biol Chem 271 (1996) 18068-18073
38. Arvelo M.B., Cooper J.T., Longo C., Daniel S., Grey S.T., Mahiou J., et al. A20 protects mice from d-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology 35 (2002) 535-543
39. Daniel S., Arvelo M.B., Patel V.I., Longo C.R., Shrikhande G., Shukri T., et al. A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation. Blood 104 (2004) 2376-2384
40. Longo C.R., Patel V.I., Shrikhande G.V., Scali S.T., Csizmadia E., Daniel S., et al. A20 protects mice from lethal radical hepatectomy by promoting hepatocyte proliferation via a p21waf1-dependent mechanism. Hepatology 42 (2005) 156-164
41. Denko N.C., Fontana L.A., Hudson K.M., Sutphin P.D., Raychaudhuri S., Altman R., et al. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 22 (2003) 5907-5914
42. Maloyan A., Eli-Berchoer L., Semenza G.L., Gerstenblith G., Stern M.D., and Horowitz M. HIF-1α-targeted pathways are activated by heat acclimation and contribute to acclimation-ischemic cross-tolerance in the heart. Physiol Genomics 23 (2005) 79-88
43. Karhausen J., Furuta G.T., Tomaszewski J.E., Johnson R.S., Colgan S.P., and Haase V.H. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest 114 (2004) 1098-1106
44. Ijichi H., Taketomi A., Yoshizumi T., Uchiyama H., Yonemura Y., Soejima Y., et al. Hyperbaric oxygen induces vascular endothelial growth factor and reduces liver injury in regenerating rat liver after partial hepatectomy. J Hepatol 45 (2006) 28-34